Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
3.64
Nov 09 • 3:59 PM ET Dollar change+0.05 Percentage change(1.25%)
Aftermarket Close
3.64
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
11.20M
Enterprise Value
17.47M
Income
-6.18M
Sales
12.07M
Book/sh
10.20
Cash/sh
0.56
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
19
IPO
Dec 22, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
0.93
P/B
0.36
P/C
6.55
P/FCF
-
EV/EBITDA
-
EV/Sales
1.45
Quick Ratio
0.27
Current Ratio
0.43
Debt/Eq
1.51
LT Debt/Eq
1.32
Option/Short
No / Yes
EPS (ttm)
-14.35
EPS next Y
-4.40
EPS next Q
-4.80
EPS this Y
-147.37%
EPS next Y
76.60%
EPS next 5Y
49.14%
EPS past 3/5Y
23.45% -77.45%
Sales past 3/5Y
77.33% 76.12%
EPS Y/Y TTM
-78.48%
Sales Y/Y TTM
3.38%
EPS Q/Q
-364.19%
Sales Q/Q
27.81%
Insider Own
14.08%
Insider Trans
-7.49%
Inst Own
6.09%
Inst Trans
-
ROA
-34.21%
ROE
-128.59%
ROIC
-53.83%
Gross Margin
34.73%
Oper. Margin
-44.77%
Profit Margin
-51.26%
SMA20
-18.78%
SMA50
-23.45%
SMA200
-68.77%
Trades
Shs Outstand
0.49M
Shs Float
0.42M
52W High
51.20 -92.88%
52W Low
3.00 21.50%
Volatility
15.25% 21.47%
ATR (14)
0.70
RSI (14)
42.37
Beta
0.78
Rel Volume
0.20
Avg Volume
111.93K
Volume
22,652
Perf Week
-3.83%
Perf Month
-9.01%
Perf Quarter
-57.22%
Perf Half Y
-69.88%
Perf YTD
-88.68%
Perf Year
-92.65%
Perf 3Y
-89.47%
Perf 5Y
-
Perf 10Y
-
Prev Close
3.60
Price
3.64
Change %
1.25%
Consensus
Strong Buy
Avg. Price Target
$40.00
Implied Upside
+997.4%
Analysts1incl. previous ratings
Rating Distribution0 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 24, 2026Downgrade
MMaxim Group
Buy → Hold
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Levy Adam R.AffilaiteSep 29 '26Proposed Sale0.1621,5003,489Sep 30 01:33 PM
Levy Adam R.Chief Executive OfficerJun 18 '26Sale0.596,0003,553327,692Jun 23 07:51 PM
Levy Adam R.Chief Executive OfficerJun 23 '26Sale0.595,0002,967322,692Jun 23 07:51 PM
Levy Adam R.Chief Executive OfficerJun 11 '26Sale0.613,0001,841333,692Jun 15 05:39 PM
Levy Adam R.Chief Executive OfficerJun 04 '26Sale0.593,0001,781339,692Jun 09 07:17 PM
Levy Adam R.Chief Executive OfficerJun 08 '26Sale0.553,0001,641336,692Jun 09 07:17 PM
Levy Adam R.Chief Executive OfficerJun 01 '26Sale0.592,0001,172342,692Jun 03 06:53 PM
Levy Adam R.Chief Executive OfficerMay 28 '26Sale0.617,0004,241347,692May 29 08:03 PM
Levy Adam R.Chief Executive OfficerMay 29 '26Sale0.603,0001,801344,692May 29 08:03 PM
Levy Adam R.Chief Executive OfficerMay 27 '26Sale0.603,0001,792354,692May 29 08:03 PM
Levy Adam R.OfficerMay 27 '26Proposed Sale0.5450,00027,065May 27 10:43 AM
Levy Adam R.Chief Executive OfficerDec 22 '25Sale1.616,0009,661361,692Dec 29 08:47 AM
Levy Adam R.Chief Executive OfficerDec 24 '25Sale1.574,0006,286357,692Dec 29 08:47 AM
Levy Adam R.OfficerDec 22 '25Proposed Sale1.6410,00016,400Dec 22 11:24 AM
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company's converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.
Interim CEO & DirectorMr. Brian J. Kieser CPA
Chief Financial OfficerMr. Ian Blackman CPA
Vice President of OperationsMr. Gregory J. Robb
Managing Director of KCSA Strategic CommunicationsMr. Valter Pinto